Showing 1 - 10 of 10 Items
Showing 1 - 10 of 10 Items
Sort By: Relevance
Journal Article
|Research
2023-09-20 • Journal of Antimicrobial Chemotherapy
2023-09-20 • Journal of Antimicrobial Chemotherapy
OBJECTIVES
To improve visceral leishmaniasis (VL) treatment in Eastern Africa, 14- and 28-day combination regimens of paromomycin plus allometrically dosed miltefosine were evaluated...
To improve visceral leishmaniasis (VL) treatment in Eastern Africa, 14- and 28-day combination regimens of paromomycin plus allometrically dosed miltefosine were evaluated...
Journal Article
|Commentary
2019-04-10 • Journal of Antimicrobial Chemotherapy
2019-04-10 • Journal of Antimicrobial Chemotherapy
Médecins Sans Frontières (MSF) has designed context-adapted antibiotic resistance (ABR) responses in countries across the Middle East. There, some health systems have been severely damag...
Journal Article
|Research
2020-03-01 • Journal of Antimicrobial Chemotherapy
2020-03-01 • Journal of Antimicrobial Chemotherapy
Objectives
Routine amoxicillin for children with uncomplicated severe acute malnutrition raises concerns of increasing antibiotic resistance. We performed an ancillary study nested ...
Routine amoxicillin for children with uncomplicated severe acute malnutrition raises concerns of increasing antibiotic resistance. We performed an ancillary study nested ...
Journal Article
|Research
2008-02-01 • Journal of Antimicrobial Chemotherapy
2008-02-01 • Journal of Antimicrobial Chemotherapy
BACKGROUND AND OBJECTIVES: Nevirapine-containing antiretroviral therapy (ART) and rifampicin-based antitubercular therapy are commonly co-administered in Africa, where nevirapine is ofte...
Journal Article
|Research
2010-07-01 • Journal of Antimicrobial Chemotherapy
2010-07-01 • Journal of Antimicrobial Chemotherapy
Mechanisms of resistance to ethambutol in Mycobacterium tuberculosis remain inadequately described. Although there is mounting evidence that mutations of codon 306 in embB play a key rol...
Journal Article
|Research
2006-10-01 • Journal of Antimicrobial Chemotherapy
2006-10-01 • Journal of Antimicrobial Chemotherapy
OBJECTIVES: Little is known about the treatment of visceral leishmaniasis (VL) in pregnancy, especially in resource-poor settings. We present a series of pregnant women with VL treated w...
Journal Article
|Research
Effect of high-dose rifampicin on efavirenz pharmacokinetics: drug-drug interaction randomized trial
2020-01-30 • Journal of Antimicrobial Chemotherapy
2020-01-30 • Journal of Antimicrobial Chemotherapy
Background: High-dose rifampicin is considered to shorten anti-TB treatment duration but its effect on antiretroviral metabolism is unknown.
Objectives: To assess the effect o...
Objectives: To assess the effect o...
Journal Article
|Review
2020-12-21 • Journal of Antimicrobial Chemotherapy
2020-12-21 • Journal of Antimicrobial Chemotherapy
BACKGROUND
Typhoid fever, caused by S. enterica ser. Typhi, continues to be a substantial health burden in developing countries. Little is known of the genotypic diversity of S. ente...
Typhoid fever, caused by S. enterica ser. Typhi, continues to be a substantial health burden in developing countries. Little is known of the genotypic diversity of S. ente...
Journal Article
|Research
2014-09-18 • Journal of Antimicrobial Chemotherapy
2014-09-18 • Journal of Antimicrobial Chemotherapy
OBJECTIVES
We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12...
We describe nevirapine and efavirenz exposure on and off tuberculosis treatment and consequences for virological efficacy and tolerance in patients included in the ANRS 12...
Journal Article
|Research
2017-06-22 • Journal of Antimicrobial Chemotherapy
2017-06-22 • Journal of Antimicrobial Chemotherapy
BACKGROUND
Up to half of patients with Chagas' disease under benznidazole treatment present adverse drug reactions (ADRs) and up to one-third do not complete standard treatment.
...
Up to half of patients with Chagas' disease under benznidazole treatment present adverse drug reactions (ADRs) and up to one-third do not complete standard treatment.
...